| Field | Row 1 |
|---|---|
| adsh | 0001641172-25-011011 |
| cik | 1471727 |
| name | SRX HEALTH SOLUTIONS, INC. |
| sic | 2080 |
| countryba | US |
| stprba | FL |
| cityba | TAMPA |
| zipba | 33626 |
| bas1 | 12400 RACE TRACK ROAD |
| bas2 | |
| baph | 813-792-4352 |
| countryma | US |
| stprma | FL |
| cityma | TAMPA |
| zipma | 33626 |
| mas1 | 12400 RACE TRACK ROAD |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 834284557 |
| former | BETTER CHOICE CO INC. |
| changed | 20190315 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250515 |
| accepted | 2025-05-15 16:38:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10-q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-011011 | 20250331 | Accounts Receivable Net Current | 4770000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Accretion Expense | 153000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Accretion Expense | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-011011 | 20241231 | Additional Paid In Capital | 330156000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Additional Paid In Capital | 330435000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Amortization Of Financing Costs And Discounts | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-011011 | 20250331 | Assets | 15288000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 3876000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Common Stock Shares Issued | 1830097.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Common Stock Shares Issued | 2520882.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Common Stock Shares Outstanding | 2520882.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Cost Of Goods And Services Sold | 4776000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Cost Of Goods And Services Sold | 2124000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Asian Business; | AsianBusiness | |
| 0001641172-25-011011 | 20250331 | Cost Of Goods And Services Sold | 4576000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Direct; | ||
| 0001641172-25-011011 | 20250331 | Income Tax Expense Benefit | 2000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Inventory Reserve | USD | 1 | 0001641172-25-011011 | ||||
| 0001641172-25-011011 | 20241231 | Liabilities And Stockholders Equity | 15801000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Net Cash Provided By Used In Investing Activities | -3000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Net Income Loss | -2830000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-011011 | 20250331 | Net Income Loss | -964000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-011011 | 20241231 | Operating Income Loss | 4192000.0000 | USD | 4 | us-gaap/2024 | Legal Entity= Asian Business; | AsianBusiness | |
| 0001641172-25-011011 | 20240331 | Other Nonoperating Income | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-011011 | 20241231 | Prepaid Expense And Other Assets Current | 484000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Prepaid Expense And Other Assets Current | 50000.0000 | USD | 0 | us-gaap/2024 | Short Term Debt Type= Convertible Debt; Type Of Arrangement= Services Agreement; | ||
| 0001641172-25-011011 | 20240331 | Repayments Of Related Party Debt | 2580000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Repayments Of Related Party Debt | 3383000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Revenue From Contract With Customer Excluding Assessed Tax | 12808000.0000 | USD | 4 | us-gaap/2024 | Legal Entity= Asian Business; | AsianBusiness | |
| 0001641172-25-011011 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 3262000.0000 | USD | 1 | us-gaap/2024 | Geographical= C N; | ||
| 0001641172-25-011011 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 733000.0000 | USD | 1 | us-gaap/2024 | Geographical= Other; | ||
| 0001641172-25-011011 | 20240331 | Shares Issued In Lieu Of Fractional Shares | 89.0000 | shares | 1 | 0001641172-25-011011 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20240331 | Shares Issued In Lieu Of Fractional Value Shares | USD | 1 | 0001641172-25-011011 | Equity Components= Common Stock; | |||
| 0001641172-25-011011 | 20231231 | Stockholders Equity | 324288000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011011 | 20250331 | Stockholders Equity | -322474000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Shares Acquisitions | 45629.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20250331 | Stock Issued During Period Shares Other | 551000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Value New Issues | 58000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-011011 | 20250331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-011011 | 20250331 | Stock Issued During Period Value Other | -1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011011 | 20250331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-011011 | 20250331 | Stock Issued During Period Value Share Based Compensation | 280000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Stock Issued During Period Value Share Based Compensation | 280000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011011 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 2605843.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Cash And Cash Equivalents At Carrying Value | 3066000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Accounts Payable Current | 2600000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Alphia Term Loan Facility; Longterm Debt Type= Line Of Credit; | ||
| 0001641172-25-011011 | 20250331 | Accrued Liabilities And Other Liabilities | 1604000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -579000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240831 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Cost Of Goods And Services Sold | 5289000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Depreciation And Amortization | 35000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Earnings Per Share Basic | -3.6000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Gross Profit | 2383000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Income Tax Expense Benefit | 10000.0000 | USD | 1 | us-gaap/2024 | Range= Maximum; | ||
| 0001641172-25-011011 | 20250331 | Income Tax Expense Benefit | 10000.0000 | USD | 1 | us-gaap/2024 | Range= Maximum; | ||
| 0001641172-25-011011 | 20240331 | Increase Decrease In Accounts Payable | 550000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Interest Income Expense Net | 83000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Interest Paid Net | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-011011 | 20250331 | Liabilities Current | 7319000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Liabilities Noncurrent | 5000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Net Cash Provided By Used In Financing Activities | -1186000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Operating Income Loss | -2466000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Other Nonoperating Income Expense | -362000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Property Plant And Equipment Net | 118000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 3200000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Contract With Customer; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Two Wholesale Customers; | ||
| 0001641172-25-011011 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 2732000.0000 | USD | 1 | us-gaap/2024 | Contract With Customer Sales Channel= Digital; | The Companys Digital channel includes two wholesale customers that amounted to greater than 10% of the Companys total net sales for the three months ended March 31, 2025 and 2024, and represented $2.7 million and $3.2 million of net sales for the three months ended March 31, 2025 and 2024, respectively. Additionally, DTC sales within the Digital channel amounted to greater than 10% of the Companys total net sales for the three months ended March 31, 2024. DTC sales within the Digital channel were approxi | |
| 0001641172-25-011011 | 20250331 | Share Based Compensation | 280000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20231231 | Shares Outstanding | 729026.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20240331 | Shares Outstanding | 823650.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20231231 | Stockholders Equity | -321342000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-011011 | 20240331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20250331 | Stockholders Equity | 7964000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Value Share Based Compensation | 518000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Value Share Based Compensation | 518000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-011011 | 20241231 | Accounts Payable Current | 1000000.0000 | USD | 0 | us-gaap/2024 | Concentration Risk By Benchmark= Inventories; Concentration Risk By Type= Supplier Concentration Risk; | ||
| 0001641172-25-011011 | 20241231 | Assets | 15801000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4455000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -1929000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240731 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | Legal Entity= Think Equity L L C; Type Of Arrangement= Underwritingagreement; | ||
| 0001641172-25-011011 | 20241231 | Common Stock Shares Outstanding | 1830097.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Common Stock Value | 2000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Cost Of Goods And Services Sold | 200000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Indirect; | ||
| 0001641172-25-011011 | 20240331 | Deferred Income Tax Expense Benefit | 2000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Earnings Per Share Basic | -0.3700 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Earnings Per Share Diluted | -3.6000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Gross Profit | 2614000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Interest Income Expense Net | -362000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Liabilities And Stockholders Equity | 15288000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Liabilities Current | 7148000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Lines Of Credit Current | 2414000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Net Cash Provided By Used In Operating Activities | 384000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-011011 | 20240331 | Operating Expenses | 5080000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Operating Lease Liability Current | 47000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Operating Lease Liability Noncurrent | 5000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Other Assets Noncurrent | 186000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Other Nonoperating Income Expense | 126000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Payments To Acquire Property Plant And Equipment | 3000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 2200000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Contract With Customer; Concentration Risk By Type= Customer Concentration Risk; Contract With Customer Sales Channel= International; Major Customers= One Customer; | ||
| 0001641172-25-011011 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 3262000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Asian Business; | AsianBusiness | |
| 0001641172-25-011011 | 20231231 | Stockholders Equity | 2947000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Stockholders Equity | -321510000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-011011 | 20240831 | Stock Issued During Period Shares New Issues | 8898069.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Stock Issued During Period Shares Share Based Compensation | 139785.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 786745.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1137000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Common Stock Value | 3000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Cost Of Goods And Services Sold | 516000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Indirect; | ||
| 0001641172-25-011011 | 20241231 | Cost Of Goods And Services Sold | 5403000.0000 | USD | 4 | us-gaap/2024 | Legal Entity= Asian Business; | AsianBusiness | |
| 0001641172-25-011011 | 20250331 | Depreciation And Amortization | 26000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Earnings Per Share Diluted | -0.3700 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Income Tax Expense Benefit | 2000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Increase Decrease In Accounts Receivable | -558000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Inventory Net | 4512000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Lines Of Credit Current | 1228000.0000 | USD | 0 | us-gaap/2024 | Credit Facility= Line Of Credit; | Interest at a variable rate of the daily U.S. Prime Rate plus 250 basis points with an interest rate floor of 5.50% per annum. | |
| 0001641172-25-011011 | 20250331 | Net Cash Provided By Used In Investing Activities | -1127000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Net Cash Provided By Used In Operating Activities | -1006000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Other Assets Noncurrent | 193000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Other Nonoperating Income | 43000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20231231 | Paid In Kind Interest | 300000.0000 | USD | 4 | us-gaap/2024 | Debt Instrument= Alphia Term Loan Facility; Longterm Debt Type= Line Of Credit; | ||
| 0001641172-25-011011 | 20250331 | Proceeds From Related Party Debt | 2197000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Provision For Doubtful Accounts | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-011011 | 20250331 | Retained Earnings Accumulated Deficit | -322474000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 4474000.0000 | USD | 1 | us-gaap/2024 | Contract With Customer Sales Channel= Digital; | ||
| 0001641172-25-011011 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 2874000.0000 | USD | 1 | us-gaap/2024 | Contract With Customer Sales Channel= International; | ||
| 0001641172-25-011011 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 3164000.0000 | USD | 1 | us-gaap/2024 | Geographical= U S; | ||
| 0001641172-25-011011 | 20240331 | Stockholders Equity | 325264000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011011 | 20241231 | Stockholders Equity | 8648000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Stockholders Equity | 330435000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011011 | 20240831 | Stock Issued During Period Shares Acquisitions | 19701935.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240731 | Stock Issued During Period Shares New Issues | 639000.0000 | shares | 0 | us-gaap/2024 | Legal Entity= Think Equity L L C; Type Of Arrangement= Underwritingagreement; | ||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Value New Issues | 58000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 2605843.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Accounts Payable Current | 2600000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Alphia Term Loan Facility; Longterm Debt Type= Line Of Credit; | ||
| 0001641172-25-011011 | 20250331 | Accounts Payable Current | 2000000.0000 | USD | 0 | us-gaap/2024 | Concentration Risk By Benchmark= Inventories; Concentration Risk By Type= Supplier Concentration Risk; | ||
| 0001641172-25-011011 | 20240331 | Amortization Of Financing Costs And Discounts | 20000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Assets Current | 14529000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Cash And Cash Equivalents At Carrying Value | 1137000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Cost Of Goods And Services Sold | 4773000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Direct; | ||
| 0001641172-25-011011 | 20250331 | Deferred Income Tax Expense Benefit | 2000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -962000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Increase Decrease In Accrued Liabilities | -707000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Increase Decrease In Inventories | -1533000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Interest Paid Net | 64000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Liabilities | 7324000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Liabilities Noncurrent | 5000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Lines Of Credit Current | 1200000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Wintrust Receivables Credit Facility; | ||
| 0001641172-25-011011 | 20240331 | Net Income Loss | -2830000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-011011 | 20250331 | Net Income Loss | -964000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Noncash Term Acquistion | 400000.0000 | USD | 1 | 0001641172-25-011011 | |||
| 0001641172-25-011011 | 20240331 | Other Noncash Income Expense | -49000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Proceeds From Related Party Debt | 3010000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Proceeds From Repayments Of Issuance Of Note Receivable | USD | 1 | 0001641172-25-011011 | ||||
| 0001641172-25-011011 | 20241231 | Property Plant And Equipment Net | 138000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Retained Earnings Accumulated Deficit | -321510000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 555000.0000 | USD | 1 | us-gaap/2024 | Contract With Customer Sales Channel= Brick And Mortar; | ||
| 0001641172-25-011011 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 5030000.0000 | USD | 1 | us-gaap/2024 | Geographical= U S; | ||
| 0001641172-25-011011 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 7159000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 3300000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Contract With Customer; Concentration Risk By Type= Customer Concentration Risk; Contract With Customer Sales Channel= International; Major Customers= One Customer; | ||
| 0001641172-25-011011 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 3995000.0000 | USD | 1 | us-gaap/2024 | Contract With Customer Sales Channel= International; | One of the Companys International customers amounted to greater than 10% of the Companys total net sales during the three months ended March 31, 2025 and 2024, and represented $3.3 million and $2.2 million of net sales for the three months ended March 31, 2025, and 2024, respectively. | |
| 0001641172-25-011011 | 20240331 | Selling General And Administrative Expense | 5080000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Shares Issued In Lieu Of Fractional Value Shares | USD | 1 | 0001641172-25-011011 | Equity Components= Retained Earnings; | |||
| 0001641172-25-011011 | 20240331 | Stockholders Equity | -324172000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-011011 | 20241231 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20231130 | Stock Issued During Period Shares Acquisitions | 6818.0000 | shares | 0 | us-gaap/2024 | Business Acquisition= Aimia Pet Healthco Inc; | ||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Shares New Issues | 6818.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Value Acquisitions | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-011011 | 20250331 | Stock Issued During Period Value New Issues | 1900000.0000 | USD | 1 | us-gaap/2024 | Credit Facility= Revolving Credit Facility; | ||
| 0001641172-25-011011 | 20250331 | Stock Issued During Period Value Other | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 786745.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Accounts Payable Current | 3137000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Assets Current | 15001000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Cost Of Goods And Services Sold | 1318000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Asian Business; | AsianBusiness | |
| 0001641172-25-011011 | 20250331 | Increase Decrease In Accrued Liabilities | 67000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 355000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 289000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Inventory Net | 3869000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Inventory Reserve | 123000.0000 | USD | 1 | 0001641172-25-011011 | |||
| 0001641172-25-011011 | 20250331 | Lines Of Credit Current | 1228000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Net Cash Provided By Used In Financing Activities | 430000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-011011 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-011011 | 20250331 | Notes And Loans Receivable Net Current | 3331000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Operating Expenses | 3471000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Operating Income Loss | 313000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Asian Business; | AsianBusiness | |
| 0001641172-25-011011 | 20250331 | Other Noncash Income Expense | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-011011 | 20240331 | Paid In Kind Interest | 125000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Proceeds From Repayments Of Issuance Of Note Receivable | -1120000.0000 | USD | 1 | 0001641172-25-011011 | |||
| 0001641172-25-011011 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1300000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Contract With Customer; Concentration Risk By Type= Customer Concentration Risk; Contract With Customer Sales Channel= Direct To Consumer; Major Customers= Two Wholesale Customers; | ||
| 0001641172-25-011011 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 2190000.0000 | USD | 1 | us-gaap/2024 | Geographical= C N; | ||
| 0001641172-25-011011 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 2190000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Asian Business; | AsianBusiness | |
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Value Acquisitions | 400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Value Acquisitions | 400000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Value Acquisitions | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-011011 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-011011 | 20240331 | Stockholders Equity | 1093000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Shares Outstanding | 2520882.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20231231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20250331 | Accounts Payable Current | 4440000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Accounts Payable Current | 100000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Director; | ||
| 0001641172-25-011011 | 20241231 | Accounts Receivable Net Current | 5371000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Goodwill | 405000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -2828000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Increase Decrease In Accounts Payable | 1304000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Increase Decrease In Accounts Receivable | -24000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Operating Income Loss | 473000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Asian Business; | AsianBusiness | |
| 0001641172-25-011011 | 20240331 | Paid In Kind Interest | 500000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Alphia Term Loan Facility; Longterm Debt Type= Line Of Credit; | ||
| 0001641172-25-011011 | 20250331 | Provision For Doubtful Accounts | 43000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 7903000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Selling General And Administrative Expense | 3471000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Shares Outstanding | 1830097.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20250331 | Stockholders Equity | 3000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-011011 | 20241231 | Accounts Payable Current | 100000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Director; | ||
| 0001641172-25-011011 | 20241231 | Accrued Liabilities And Other Liabilities | 1535000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 3066000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Goodwill | 405000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Increase Decrease In Inventories | 643000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Liabilities | 7153000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Lines Of Credit Current | 2414000.0000 | USD | 0 | us-gaap/2024 | Credit Facility= Line Of Credit; | ||
| 0001641172-25-011011 | 20250331 | Noncash Term Acquistion | USD | 1 | 0001641172-25-011011 | ||||
| 0001641172-25-011011 | 20241231 | Notes And Loans Receivable Net Current | 2211000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Operating Income Loss | -1088000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Operating Lease Liability Current | 62000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Operating Lease Liability Noncurrent | 5000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20241231 | Operating Lease Right Of Use Asset | 64000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Operating Lease Right Of Use Asset | 50000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Paid In Kind Interest | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-011011 | 20250331 | Payments To Acquire Property Plant And Equipment | 7000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20250331 | Prepaid Expense And Other Assets Current | 779000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 683000.0000 | USD | 1 | us-gaap/2024 | Geographical= Other; | ||
| 0001641172-25-011011 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 2700000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Contract With Customer; Concentration Risk By Type= Customer Concentration Risk; Major Customers= Two Wholesale Customers; | ||
| 0001641172-25-011011 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 432000.0000 | USD | 1 | us-gaap/2024 | Contract With Customer Sales Channel= Brick And Mortar; | None of the Companys Brick & Mortar customers represented greater than 10% of net sales for the three months ended March 31, 2025 or 2024. For the three months ended March 31, 2024, Petco was included within the Brick & Mortar channel. Beginning in Q1 2024, Petco is presented within Digital as a result of the strategic exit out of Petco stores, while remaining on Petco.com. | |
| 0001641172-25-011011 | 20240331 | Share Based Compensation | 518000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Shares Issued In Lieu Of Fractional Value Shares | USD | 1 | 0001641172-25-011011 | ||||
| 0001641172-25-011011 | 20240331 | Shares Issued In Lieu Of Fractional Value Shares | USD | 1 | 0001641172-25-011011 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-011011 | 20241231 | Stockholders Equity | 330156000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011011 | 20240229 | Stock Issued During Period Shares New Issues | 70039.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Shares Share Based Compensation | 42088.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011011 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Other Nonoperating Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income | Amount of income related to nonoperating activities, classified as other. |
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Proceeds From Repayments Of Issuance Of Note Receivable | 0001641172-25-011011 | 1 | 0 | monetary | D | D | ProceedsFromRepaymentsOfIssuanceOfNoteReceivable | Proceeds from repayments of issuance of note receivable. |
| Shares Issued In Lieu Of Fractional Shares | 0001641172-25-011011 | 1 | 0 | shares | D | Shares issued in lieu of fractional shares, shares | Shares issued in lieu of fractional shares. | |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Inventory Reserve | 0001641172-25-011011 | 1 | 0 | monetary | D | C | InventoryReserve | Inventory reserve. |
| Shares Issued In Lieu Of Fractional Value Shares | 0001641172-25-011011 | 1 | 0 | monetary | D | C | Shares issued in lieu of fractional shares | Shares issued in lieu of fractional value shares. |
| Accrued Liabilities And Other Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities and Other Liabilities | Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Lines Of Credit Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Line of Credit, Current | The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Paid In Kind Interest | us-gaap/2024 | 0 | 0 | monetary | D | D | Paid-in-Kind Interest | Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Stock Issued During Period Value Acquisitions | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Acquisitions | Value of stock issued pursuant to acquisitions during the period. |
| Noncash Term Acquistion | 0001641172-25-011011 | 1 | 0 | monetary | D | C | Aimia acquisition | Noncash term acquistion. |
| Amortization Of Financing Costs And Discounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs and Discounts | Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Other Noncash Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Noncash Income (Expense) | Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. |
| Repayments Of Related Party Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Related Party Debt | The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates. |
| Deferred Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Deferred Income Tax Expense (Benefit) | Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. |
| Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
| Interest Income Expense Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income (Expense), Operating | Amount of interest income (expense) classified as operating. |
| Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Stock Issued During Period Shares Other | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Other | Number of shares of stock issued attributable to transactions classified as other. | |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Accretion Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Accretion Expense | Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Proceeds From Related Party Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Notes And Loans Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Financing Receivable, after Allowance for Credit Loss, Current | Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Provision For Doubtful Accounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Accounts Receivable, Credit Loss Expense (Reversal) | Amount of expense (reversal of expense) for expected credit loss on accounts receivable. |
| Stock Issued During Period Shares Acquisitions | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Acquisitions | Number of shares of stock issued during the period pursuant to acquisitions. | |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Stock Issued During Period Value Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-011011 | 3 | 15 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001641172-25-011011 | 2 | 1 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Net sales | 0 |
| 0001641172-25-011011 | 2 | 2 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Cost of goods sold | 0 |
| 0001641172-25-011011 | 2 | 3 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit | 0 |
| 0001641172-25-011011 | 2 | 5 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general and administrative | 0 |
| 0001641172-25-011011 | 2 | 6 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001641172-25-011011 | 2 | 7 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001641172-25-011011 | 2 | 9 | IS | 0 | H | Interest Income Expense Net | us-gaap/2024 | Interest income (expense), net | 0 |
| 0001641172-25-011011 | 2 | 10 | IS | 0 | H | Other Nonoperating Income | us-gaap/2024 | Other income | 0 |
| 0001641172-25-011011 | 2 | 11 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Total other income (expense), net | 0 |
| 0001641172-25-011011 | 2 | 12 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income taxes | 0 |
| 0001641172-25-011011 | 2 | 13 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax expense | 0 |
| 0001641172-25-011011 | 2 | 14 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-011011 | 2 | 15 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average number of shares outstanding, basic | 0 |
| 0001641172-25-011011 | 2 | 16 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average number of shares outstanding, diluted | 0 |
| 0001641172-25-011011 | 2 | 17 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share, basic | 0 |
| 0001641172-25-011011 | 2 | 18 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share, diluted | 0 |
| 0001641172-25-011011 | 3 | 2 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001641172-25-011011 | 3 | 3 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net | 0 |
| 0001641172-25-011011 | 3 | 4 | BS | 0 | H | Notes And Loans Receivable Net Current | us-gaap/2024 | Notes receivable | 0 |
| 0001641172-25-011011 | 3 | 5 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventories | 0 |
| 0001641172-25-011011 | 3 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001641172-25-011011 | 3 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total Current Assets | 0 |
| 0001641172-25-011011 | 3 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Fixed assets, net | 0 |
| 0001641172-25-011011 | 3 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Right-of-use assets, operating leases | 0 |
| 0001641172-25-011011 | 3 | 10 | BS | 0 | H | Goodwill | us-gaap/2024 | Goodwill | 0 |
| 0001641172-25-011011 | 3 | 11 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0001641172-25-011011 | 3 | 12 | BS | 0 | H | Assets | us-gaap/2024 | Total Assets | 0 |
| 0001641172-25-011011 | 3 | 16 | BS | 0 | H | Accrued Liabilities And Other Liabilities | us-gaap/2024 | Accrued and other liabilities | 0 |
| 0001641172-25-011011 | 3 | 17 | BS | 0 | H | Lines Of Credit Current | us-gaap/2024 | Credit facility, net | 0 |
| 0001641172-25-011011 | 3 | 18 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liability | 0 |
| 0001641172-25-011011 | 3 | 19 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total Current Liabilities | 0 |
| 0001641172-25-011011 | 3 | 21 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability | 0 |
| 0001641172-25-011011 | 3 | 22 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2024 | Total Non-current Liabilities | 0 |
| 0001641172-25-011011 | 3 | 23 | BS | 0 | H | Liabilities | us-gaap/2024 | Total Liabilities | 0 |
| 0001641172-25-011011 | 3 | 25 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common Stock, $0.001 par value, 200,000,000 shares authorized, 2,520,882 & 1,830,097 shares issued and outstanding as of March 31, 2025, and December 31, 2024, respectively | 0 |
| 0001641172-25-011011 | 3 | 26 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001641172-25-011011 | 3 | 27 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001641172-25-011011 | 3 | 28 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Stockholders Equity | 0 |
| 0001641172-25-011011 | 3 | 29 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total Liabilities and Stockholders Equity | 0 |
| 0001641172-25-011011 | 4 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001641172-25-011011 | 4 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001641172-25-011011 | 4 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001641172-25-011011 | 4 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001641172-25-011011 | 5 | 8 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-011011 | 5 | 9 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-011011 | 5 | 10 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Share-based compensation | 0 |
| 0001641172-25-011011 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | Share-based compensation, shares | 0 |
| 0001641172-25-011011 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Value Other | us-gaap/2024 | Warrant exercise | 0 |
| 0001641172-25-011011 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Shares Other | us-gaap/2024 | Warrant exercise, shares | 0 |
| 0001641172-25-011011 | 5 | 14 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-011011 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Share issuance | 0 |
| 0001641172-25-011011 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Share issuance, shares | 0 |
| 0001641172-25-011011 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Value Acquisitions | us-gaap/2024 | Equity issued in business combinations | 0 |
| 0001641172-25-011011 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Shares Acquisitions | us-gaap/2024 | Equity issued in business combinations, shares | 0 |
| 0001641172-25-011011 | 5 | 19 | EQ | 0 | H | Shares Issued In Lieu Of Fractional Value Shares | 0001641172-25-011011 | Shares issued in lieu of fractional shares | 0 |
| 0001641172-25-011011 | 5 | 20 | EQ | 0 | H | Shares Issued In Lieu Of Fractional Shares | 0001641172-25-011011 | Shares issued in lieu of fractional shares, shares | 0 |
| 0001641172-25-011011 | 5 | 21 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-011011 | 5 | 22 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-011011 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net income (loss) | 0 |
| 0001641172-25-011011 | 6 | 4 | CF | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001641172-25-011011 | 6 | 5 | CF | 0 | H | Amortization Of Financing Costs And Discounts | us-gaap/2024 | Amortization of debt issuance costs | 0 |
| 0001641172-25-011011 | 6 | 6 | CF | 0 | H | Inventory Reserve | 0001641172-25-011011 | Inventory reserve | 1 |
| 0001641172-25-011011 | 6 | 7 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation | 0 |
| 0001641172-25-011011 | 6 | 8 | CF | 0 | H | Paid In Kind Interest | us-gaap/2024 | PIK interest expense on term loan | 0 |
| 0001641172-25-011011 | 6 | 9 | CF | 0 | H | Accretion Expense | us-gaap/2024 | Accreted interest expense on term loan | 0 |
| 0001641172-25-011011 | 6 | 10 | CF | 0 | H | Other Noncash Income Expense | us-gaap/2024 | Other | 1 |
| 0001641172-25-011011 | 6 | 11 | CF | 0 | H | Provision For Doubtful Accounts | us-gaap/2024 | Bad debt expense | 0 |
| 0001641172-25-011011 | 6 | 12 | CF | 0 | H | Deferred Income Tax Expense Benefit | us-gaap/2024 | Income tax provision | 0 |
| 0001641172-25-011011 | 6 | 14 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001641172-25-011011 | 6 | 15 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventories | 1 |
| 0001641172-25-011011 | 6 | 16 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other assets | 1 |
| 0001641172-25-011011 | 6 | 17 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001641172-25-011011 | 6 | 18 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued and other liabilities | 0 |
| 0001641172-25-011011 | 6 | 19 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Cash (Used in) Provided by Operating Activities | 0 |
| 0001641172-25-011011 | 6 | 21 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Capital expenditures | 1 |
| 0001641172-25-011011 | 6 | 22 | CF | 0 | H | Proceeds From Repayments Of Issuance Of Note Receivable | 0001641172-25-011011 | Notes receivable | 0 |
| 0001641172-25-011011 | 6 | 23 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Cash Used in Investing Activities | 0 |
| 0001641172-25-011011 | 6 | 25 | CF | 0 | H | Proceeds From Related Party Debt | us-gaap/2024 | Proceeds from Wintrust Facility | 0 |
| 0001641172-25-011011 | 6 | 26 | CF | 0 | H | Repayments Of Related Party Debt | us-gaap/2024 | Payments on Wintrust Facility | 1 |
| 0001641172-25-011011 | 6 | 27 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Cash Provided by (Used in) Financing Activities | 0 |
| 0001641172-25-011011 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net decrease in cash and cash equivalents | 0 |
| 0001641172-25-011011 | 6 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Total cash and cash equivalents, beginning of period | 0 |
| 0001641172-25-011011 | 6 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Total cash and cash equivalents, end of period | 0 |
| 0001641172-25-011011 | 6 | 32 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest during the period | 0 |
| 0001641172-25-011011 | 6 | 34 | CF | 0 | H | Noncash Term Acquistion | 0001641172-25-011011 | Aimia acquisition | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |